Files

686009.pdf (751.38 KB)

Document type

Article

Version

Accepted version

Publication date

2018-09

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/133762

Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in Spain

Journal Title

Authors

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Iron deficiency is a frequent complication of chronic kidney disease (CKD) that is associated with a decrease in the quality of life of patients and an increase in the risk of other clinical complications. Iron therapy represents one of the fundamentals of patients with CKD. Sucrosomial® oral iron allows Fisiogen Ferro Forte® to be used in all patients who are intolerant to treatment by the oral route of administration, or who present with malabsorption of conventional oral iron preparations.

Related resource

https://doi.org/10.1007/s40261-018-0666-9

Subject

Dèficit de ferro, Insuficiència renal crònica, Anàlisi econòmica, Cost de l'assistència sanitària

Subject (English)

Iron deficiency diseases, Chronic renal failure, Economic analysis, Cost of medical care

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep and ASCANIO, Meritxell. Budget impact analysis of oral Fisiogen Ferro Forte versus intravenous iron for the management of iron deficiency in chronic kidney disease in Spain. Clinical Drug Investigation. 2018. Vol. 38, num. 9, pags. 801-811. ISSN 1173-2563. [consulted: 15 of October of 2026]. Available at: https://hdl.handle.net/2445/133762

Export metadata

JSON - METS

Share record